Latest On CRH Medical Corporation (CRHM):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2021-04-23 11:08 EST | News | WELL Health Technologies falls after new short report from Grizzly Research | N/A |  |
| 2021-04-17 05:13 EST | News | CRH Medical securityholders approve of acquisition by WELL Health | N/A | |
| 2021-04-06 01:20 EST | News | CRH Medical acquires remaining stake in Lake Lanier Anesthesia Associates | N/A | |
| 2021-03-18 04:27 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-12 02:03 EST | News | CRH Medical expands in Florida with the new joint venture | N/A | |
| 2021-02-23 12:37 EST | News | CRH Medical inks management services agreement with United Digestive | N/A | |
| 2021-02-10 09:27 EST | News | WELL Health buying CRH Medical in $300M deal; CRHM shares up 80% | N/A | |
| 2021-02-10 09:26 EST | News | CRH Medical (CRHM) buys Oak Tree Anesthesia Associates | N/A | |
| 2020-12-24 04:26 EST | News | CRH Medical is down -23% as major customer exits service agreement | N/A | |
| 2020-12-24 04:26 EST | News | WATT, MVIS, SOL and ONTX among midday movers | N/A | |
| 2020-12-13 03:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-18 03:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-17 03:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-14 00:34 EST | News | CRH Medical beats on revenue | N/A | |
| 2020-11-14 00:33 EST | News | CRH Medical Corp (CRHM) CEO Tushar Ramani on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-07 15:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 12:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 04:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-05 00:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-18 05:26 EST | News | CRH Medical Corporation: Needing Their Service And Owning Their Stock Might Make You Forget The 'Prep' | N/A | |
| 2020-08-17 22:33 EST | Insider Trade | James Kreger has directly disposed of 9,900 shares and currently holds 68,600 shares. | Sell | |
| 2020-08-17 22:33 EST | Insider Trade | James Kreger has directly acquired 25,000 shares and currently holds 78,500 shares. | Buy | |
| 2020-08-13 04:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-12 13:13 EST | News | CRH Medical Corporation (CRHM) CEO Tushar Ramani on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-11 11:26 EST | News | CRH Medical EPS misses by $0.91, beats on revenue | N/A | |
| 2020-07-31 00:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 16:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-08 07:47 EST | News | CRH Medical acquires 51% stake in Central Virginia Anesthesia Associates | N/A | |
| 2020-07-03 04:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 08:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-22 23:20 EST | News | CRH Medical buys majority stake in Metro Orlando Anesthesia Associates | N/A | |
| 2020-06-04 18:56 EST | Insider Trade | James Kreger has directly disposed of 10,000 shares and currently holds 41,000 shares. | Sell | |
| 2020-06-04 18:56 EST | Insider Trade | James Kreger has directly acquired 25,000 shares and currently holds 51,000 shares. | Buy | |
| 2020-06-04 18:56 EST | Insider Trade | Richard Bear has directly disposed of 12,000 shares and currently holds 353,000 shares. | Sell | |
| 2020-06-04 18:56 EST | Insider Trade | Richard Bear has directly acquired 30,000 shares and currently holds 365,000 shares. | Buy | |
| 2020-06-04 18:56 EST | Insider Trade | James Kreger has directly disposed of 12,500 shares and currently holds 53,500 shares. | Sell | |
| 2020-06-04 18:56 EST | Insider Trade | James Kreger has directly acquired 25,000 shares and currently holds 66,000 shares. | Buy | |
| 2020-06-04 18:56 EST | Insider Trade | Ian Webb has directly disposed of 16,200 shares and currently holds 154,100 shares. | Sell | |
| 2020-06-04 18:56 EST | Insider Trade | Ian Webb has directly disposed of 8,800 shares and currently holds 170,300 shares. | Sell | |
| 2020-06-04 18:56 EST | Insider Trade | David Allan Johnson has directly acquired 5,000 shares and currently holds 408,900 shares. | Buy | |
| 2020-06-04 18:56 EST | Insider Trade | David Allan Johnson has directly acquired 5,000 shares and currently holds 403,900 shares. | Buy | |
| 2020-06-04 18:56 EST | Insider Trade | David Allan Johnson has directly acquired 5,000 shares and currently holds 423,900 shares. | Buy | |
| 2020-06-04 18:56 EST | Insider Trade | David Allan Johnson has directly acquired 10,000 shares and currently holds 418,900 shares. | Buy | |
| 2020-05-31 16:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-15 22:41 EST | News | CRH Medical Corporation (CRHM) CEO Tushar Ramani on Q1 2020 Results - Earnings Call Transcript | N/A | |
| 2020-05-15 20:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-03 08:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-11 09:48 EST | News | CRH Medical misses on revenue | N/A | |
| 2020-04-07 12:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-07 00:39 EST | Financials | Company financials have been released. | Neutral | |
About CRH Medical Corporation (CRHM):
CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company also distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. It serves 65 ambulatory surgical/endoscopy centers in 13 states. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was incorporated in 2001 and is headquartered in Vancouver, Canada.
General
- Name CRH Medical Corporation
- Symbol CRHM
- Type Common Stock
- Exchange NYSE MKT
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 133
- Fiscal Year EndDecember
- IPO Date2015-09-03
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Providers & Services
- Gic SubIndustryHealth Care Services
- Web URLhttp://www.crhmedcorp.com
View More
Valuation
- Trailing PE 39.62
- Forward PE 192.31
- Price/Sales (Trailing 12 Mt.) 2.78
- Price/Book (Most Recent Quarter) 3.82
- Enterprise Value Revenue 3.5
- Enterprise Value EBITDA 9.41
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin -23%
- Operating Margin -6%
- Return on Assets -2%
- Return on Equity -20%
- Revenue 106.17 million
- Earnings Per Share $0.02
- Revenue Per Share $1.48
- Gross Profit 2.2 million
- Quarterly Earnings Growth 21.1%
View More
Highlights
- Market Capitalization 280.85 million
- EBITDA 34.16 million
- Analyst Target Price $3.4
- Book Value Per Share $0.75
View More
Share Statistics
- Shares Outstanding 71.41 million
- Shares Float 58.28 million
- % Held by Insiders 370%
- % Held by Institutions 45.46%
- Shares Short 44682
- Shares Short Prior Month 95615
- Short Ratio 0.02
View More
Technicals
- Beta 3.08
- 52 Week High $3.95
- 52 Week Low $1
- 50 Day Moving Average 3.53
- 200 Day Moving Average 2.66
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
CRH Medical Corporation (CRHM) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
CRH Medical Corporation (CRHM) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-16 | $36.78 million | -$0.27 | ||
| 2020-09-30 | 2020-11-12 | $30.35 million | $-0.00 | -$0.03 | 87% |
| 2020-06-30 | 2020-08-10 | $N/A | -$0.04 | -$0.04 | -15.71% |
| 2020-03-31 | 2020-05-12 | $25.45 million | -$0.03 | $0.01 | -382% |
| 2019-12-31 | 2020-03-11 | $30.37 million | $0.02 | $0.03 | -43.33% |
| 2019-09-30 | 2019-11-07 | $30.41 million | $0.01 | $0.01 | 44% |
| 2019-06-30 | 2019-07-31 | $30.48 million | $0.02 | $0.01 | 123% |
| 2019-03-31 | 2019-05-01 | $29.12 million | $-0.00 | $0.01 | -108% |
| 2018-12-31 | 2019-03-13 | $32.02 million | $0.02 | $0.02 | 15.5% |
| 2018-09-30 | 2018-10-31 | $28.73 million | $0.01 | $0.04 | -84.86% |
| 2018-06-30 | 2018-08-01 | $27.33 million | $0.02 | $0.01 | 40.6% |
| 2018-03-31 | 2018-04-30 | $24.67 million | $0.02 | $0.03 | -32% |
| 2017-12-31 | 2018-03-05 | $32.3 million | $0.04 | $0.04 | 20.22% |
| 2017-09-30 | 2017-11-01 | $22.16 million | $0.03 | $0.03 | 0% |
| 2017-06-30 | 2017-08-02 | $20.93 million | -$0.01 | $0.04 | -116.79% |
| 2017-03-31 | 2017-04-26 | $21.37 million | $0.02 | $0.04 | -45.5% |
| 2016-12-31 | 2017-02-22 | $25.82 million | $0.05 | $0.04 | 9.52% |
| 2016-09-30 | 2016-10-27 | $22.11 million | $0.04 | $0.04 | -2.01% |
| 2016-06-30 | 2016-07-28 | $16.59 million | $0.02 | $0.04 | -54.67% |
| 2016-03-31 | 2016-04-27 | $13.84 million | $0.04 | $0.03 | 60% |
| 2015-12-31 | 2016-02-25 | $13.94 million | $0.00 | $0.03 | -97% |
| 2015-09-30 | 2015-10-29 | $11.61 million | $0.02 | $0.03 | -33.33% |
| 2015-06-30 | 2015-07-30 | $10.88 million | -$0.01 | $0.04 | -125% |
| 2015-03-31 | 2015-04-29 | $9.62 million | $0.03 | $0.04 | -25% |
| 2014-12-31 | 2015-02-13 | $5.75 million | $0.01 | $0.01 | 0% |
| 2014-09-30 | 2014-10-27 | $2.2 million | $0.01 | $0.01 | 0% |
| 2014-06-30 | 2014-07-31 | $2.05 million | $0.01 | $0.01 | 0% |
| 2014-03-31 | 2014-04-24 | $1.99 million | $0.01 | ||
| 2013-12-31 | 2014-03-19 | $2.04 million | $0.02 | $0.01 | 100% |
| 2013-09-30 | 2013-10-28 | $1.85 million | $0.01 | $0.01 | 0% |
| 2013-06-30 | 2013-07-22 | $1.94 million | $0.01 | $0.01 | 0% |
| 2013-03-31 | 2013-04-23 | $1.83 million | $0.01 | $0.08 | -87.5% |
| 2012-12-31 | 2013-03-21 | $1.74 million | $0.01 | ||
| 2012-09-30 | 2012-10-18 | $1.72 million | $0.01 | $0.01 | 0% |
| 2012-06-30 | 2012-08-02 | $1.69 million | $0.01 | $0.01 | 0% |
| 2012-03-31 | 2012-04-23 | $1.7 million | $0.01 | $0.01 | 0% |
| 2011-09-30 | 2011-10-25 | $1.38 million | $0.01 | $0.00 | |
| 2011-06-30 | 2011-08-03 | $1.35 million | $0.01 | $0.00 | |
| 2011-03-31 | 2011-04-25 | $1.25 million | -$0.01 | $0.00 | |
| 2010-09-30 | 2010-10-29 | $927023.61 | -$0.01 | $0.00 | |
| 2010-06-30 | 2010-08-13 | $861356.38 | -$0.01 | $0.00 | |
| 2010-03-31 | 2010-04-27 | $715974 | -$0.02 | $0.00 | |
| 2009-12-31 | 2010-03-03 | -$0.02 | |||
| 2009-09-30 | 2009-11-30 | -$0.01 | $0.00 | ||
| 2009-06-30 | 2009-08-10 | -$0.01 | -$0.01 | 0% | |
| 2009-03-31 | 2009-04-30 | -$0.02 | -$0.02 | 0% | |
| 2008-12-31 | 2009-02-25 | -$0.02 | |||
| 2008-09-30 | 2008-11-26 | -$0.02 | -$0.02 | 0% | |
| 2008-06-30 | 2008-08-28 | -$0.02 | -$0.02 | 0% | |
| 2008-03-31 | 2008-05-29 | -$0.02 | -$0.01 | -100% | |
| 2007-12-31 | 2008-02-27 | -$0.02 | |||
| 2007-09-30 | 2007-11-27 | -$0.02 | -$0.02 | 0% | |
| 2007-06-30 | 2007-06-30 | -$0.02 | |||
| 2007-03-31 | 2007-03-31 | -$0.03 |
CRH Medical Corporation (CRHM) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | -23.62 million | -67471 | N/A | -3.11 million | 2.99 million |
| Selling General Administrative | 2.1 million | 2.22 million | N/A | 2.23 million | 1.03 million |
| Gross Profit | 5.9 million | 2.3 million | N/A | -366058 | 4.5 million |
| Ebit | -12.22 million | 11.12 million | N/A | 6.89 million | 3.47 million |
| Operating Income | 3.81 million | 84827 | N/A | -2.6 million | 3.47 million |
| Income Tax Expense | N/A | N/A | -233518 | N/A | 891009 |
| Total Revenue | 36.78 million | 30.35 million | N/A | 25.45 million | 30.37 million |
| Cost of Revenue | 30.88 million | 28.04 million | N/A | 25.82 million | 25.87 million |
| Total Other Income Expense Net | -26.9 million | 370038 | N/A | 165181 | -474891 |
| Net Income From Continuing Operations | -17.66 million | 308766 | N/A | -2.13 million | 2.1 million |
| Net Income Applicable to Common Shares | N/A | N/A | -2.91 million | N/A | 1.22 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | -160888 | 44250 | N/A |
| Change to Liabilities | -640539 | 3.32 million | N/A | 29889 | -83936 |
| Total Cash Flow from Investing Activities | -13 million | -8.38 million | N/A | -6.37 million | -4.7 million |
| Net Borrowings | 9.48 million | -4.82 million | N/A | 1 million | 1.36 million |
| Total Cash Flow from Financial Activities | N/A | N/A | -857285 | -4.62 million | -3.36 million |
| Change to Operating Activities | 238499 | -28627 | N/A | -259338 | 76391 |
| Change in Cash | N/A | N/A | 6.76 million | 1.35 million | 2.65 million |
| Total Cash from Operating Activities | 7.82 million | 9.19 million | 7.78 million | 12.34 million | 10.71 million |
| Depreciation | N/A | N/A | 9.41 million | 9.03 million | 8.56 million |
| Other Cash Flow from Investing Activities | 56488 | -89170 | N/A | -58809 | 130837 |
| Change to Inventory | N/A | N/A | 26506 | 7911 | 153837 |
| Change to Account Receivables | N/A | N/A | N/A | 1.48 million | -182433 |
| Other Cash Flow from Financing Activities | -4.14 million | -3.87 million | N/A | -4.86 million | -3.62 million |
| Change to Net Income | 257075 | -791623 | N/A | -351356 | 44801 |
| Capital Expenditures | N/A | N/A | 1636 | 13827 | 4834 |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 85.84 million | 89.79 million | N/A | 78.94 million | 78.88 million |
| Total Stockholder Equity | 53.72 million | 72.27 million | N/A | 74.78 million | 76.31 million |
| Other Current Liabilities | 907459 | 686973 | N/A | 872068 | 2.96 million |
| Total Assets | 191.78 million | 214.25 million | N/A | 199.34 million | 203.1 million |
| Common Stock | N/A | 56.27 million | 56.24 million | N/A | 56.06 million |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -11.87 million | 7.42 million | 7.96 million | 11.01 million | 13.15 million |
| Other Liabilities | N/A | 2.73 million | 396036 | N/A | 101822 |
| Other Assets | N/A | 13.17 million | 12.36 million | N/A | 10.5 million |
| Cash | 3.92 million | 5.1 million | N/A | 13.33 million | 6.57 million |
| Total Current Liabilities | 11.77 million | 11.19 million | N/A | 8.36 million | 10.34 million |
| Other Stockholder Equity | N/A | -66772 | -66772 | N/A | -66772 |
| Property, Plant & Equipment | N/A | 1.3 million | 362781 | N/A | 466787 |
| Total Current Assets | 31.54 million | 29.44 million | N/A | 34.23 million | 29.02 million |
| Long Term Investments | 2.12 million | 2.02 million | N/A | N/A | N/A |
| Net Tangible Assets | N/A | -96.05 million | -83.41 million | N/A | -86.8 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | 70.6 million | 75 million | N/A | 70.44 million | 68.38 million |
| Inventory | 262466 | 296070 | N/A | 322818 | 349324 |
| Accounts Payable | 946758 | 3.78 million | N/A | 1.06 million | 1.21 million |
CRH Medical Corporation (CRHM) Chart:
CRH Medical Corporation (CRHM) News:
Below you will find a list of latest news for CRH Medical Corporation (CRHM) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
CRH Medical Corporation (CRHM) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
CRH Medical Corporation (CRHM) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920000963/0001279569-20-000963-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1461119/000089542120000068/0000895421-20-000068-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1461119/000093583620000129/0000935836-20-000129-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1461119/000110465920019173/0001104659-20-019173-index.htm |
| 2020-05-06 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1461119/000119312520134993/0001193125-20-134993-index.htm |
| 2020-05-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1461119/000119312520135002/0001193125-20-135002-index.htm |
| 2020-10-09 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000119312520266995/0001193125-20-266995-index.htm |
| 2020-10-09 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000119312520266999/0001193125-20-266999-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000119312520286524/0001193125-20-286524-index.htm |
| 2019-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919119046814/0001209191-19-046814-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919119061826/0001209191-19-061826-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919119061828/0001209191-19-061828-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919119061900/0001209191-19-061900-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919120031777/0001209191-20-031777-index.htm |
| 2020-05-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919120032125/0001209191-20-032125-index.htm |
| 2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919120032126/0001209191-20-032126-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919120032582/0001209191-20-032582-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919120036820/0001209191-20-036820-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919120036821/0001209191-20-036821-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919120036822/0001209191-20-036822-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919120036823/0001209191-20-036823-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919120047083/0001209191-20-047083-index.htm |
| 2020-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919120054261/0001209191-20-054261-index.htm |
| 2020-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919120054262/0001209191-20-054262-index.htm |
| 2020-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1461119/000120919120054263/0001209191-20-054263-index.htm |
| 2019-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956919001614/0001279569-19-001614-index.htm |
| 2019-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956919001621/0001279569-19-001621-index.htm |
| 2019-09-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956919001875/0001279569-19-001875-index.htm |
| 2019-10-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956919002159/0001279569-19-002159-index.htm |
| 2019-10-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956919002170/0001279569-19-002170-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956919002281/0001279569-19-002281-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956919002283/0001279569-19-002283-index.htm |
| 2019-11-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956919002366/0001279569-19-002366-index.htm |
| 2019-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956919002499/0001279569-19-002499-index.htm |
| 2020-01-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920000010/0001279569-20-000010-index.htm |
| 2020-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920000264/0001279569-20-000264-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920000285/0001279569-20-000285-index.htm |
| 2020-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920000336/0001279569-20-000336-index.htm |
| 2020-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920000563/0001279569-20-000563-index.htm |
| 2020-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920000607/0001279569-20-000607-index.htm |
| 2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920000658/0001279569-20-000658-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920000743/0001279569-20-000743-index.htm |
| 2020-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920000900/0001279569-20-000900-index.htm |
| 2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920000963/0001279569-20-000963-index.htm |
| 2020-07-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920001030/0001279569-20-001030-index.htm |
| 2020-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920001135/0001279569-20-001135-index.htm |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920001141/0001279569-20-001141-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920001188/0001279569-20-001188-index.htm |
| 2020-09-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920001257/0001279569-20-001257-index.htm |
| 2020-10-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000127956920001402/0001279569-20-001402-index.htm |
| 2019-10-29 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000134100419000524/0001341004-19-000524-index.htm |
| 2020-03-23 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000134100420000098/0001341004-20-000098-index.htm |
| 2020-04-28 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000134100420000160/0001341004-20-000160-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000134100420000165/0001341004-20-000165-index.htm |
| 2020-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1461119/000134100420000247/0001341004-20-000247-index.htm |
| 2019-07-31 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1461119/000156459019027492/0001564590-19-027492-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1461119/000156459019041854/0001564590-19-041854-index.htm |
| 2020-03-11 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1461119/000156459020010121/0001564590-20-010121-index.htm |
| 2020-05-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1461119/000156459020024719/0001564590-20-024719-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1461119/000156459020038983/0001564590-20-038983-index.htm |
| 2020-02-12 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1461119/999999999720000639/9999999997-20-000639-index.htm |
| 2020-03-03 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1461119/999999999720001105/9999999997-20-001105-index.htm |
CRH Medical Corporation (CRHM) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of CRH Medical Corporation (CRHM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 370%Institutional Ownership: 4546%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-12-24 | Ian Webb | Director | Sell | 16,200.00 | 3.46 | 56,052.00 | 154,100.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919119061900/0001209191-19-061900-index.htm |
| 2019-12-23 | Ian Webb | Director | Sell | 8,800.00 | 3.54 | 31,152.00 | 170,300.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919119061900/0001209191-19-061900-index.htm |
| 2019-12-19 | Richard Bear | Chief Financial Officer | Sell | 12,000.00 | 3.70 | 44,400.00 | 353,000.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919119061826/0001209191-19-061826-index.htm |
| 2019-12-18 | Richard Bear | Chief Financial Officer | Buy | 30,000.00 | 365,000.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919119061826/0001209191-19-061826-index.htm | ||
| 2020-05-20 | David Allan Johnson | Director | Buy | 5,000.00 | 1.92 | 9,598.50 | 403,900.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919120031777/0001209191-20-031777-index.htm |
| 2020-05-21 | David Allan Johnson | Director | Buy | 5,000.00 | 1.97 | 9,848.00 | 408,900.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919120031777/0001209191-20-031777-index.htm |
| 2019-08-15 | James Kreger | President | Sell | 10,000.00 | 3.24 | 32,400.00 | 41,000.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919119046814/0001209191-19-046814-index.htm |
| 2020-05-22 | David Allan Johnson | Director | Buy | 10,000.00 | 1.92 | 19,182.00 | 418,900.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919120032126/0001209191-20-032126-index.htm |
| 2020-05-26 | David Allan Johnson | Director | Buy | 5,000.00 | 1.95 | 9,749.50 | 423,900.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919120032126/0001209191-20-032126-index.htm |
| 2019-08-15 | James Kreger | President | Buy | 25,000.00 | 51,000.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919119046814/0001209191-19-046814-index.htm | ||
| 2019-12-19 | James Kreger | President | Sell | 12,500.00 | 3.73 | 46,625.00 | 53,500.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919119061828/0001209191-19-061828-index.htm |
| 2019-12-18 | James Kreger | President | Buy | 25,000.00 | 66,000.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919119061828/0001209191-19-061828-index.htm | ||
| 2020-08-12 | James Kreger | President | Sell | 9,900.00 | 2.68 | 26,532.00 | 68,600.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919120047083/0001209191-20-047083-index.htm |
| 2020-08-12 | James Kreger | President | Buy | 25,000.00 | 78,500.00 | https://www.sec.gov/Archives/edgar/data/1461119/000120919120047083/0001209191-20-047083-index.htm |